A pioneer in integrative skin care solutions takes advanced anti-ageing solutions to new heights with technology inspired by the effects of neurotoxin injections.
new york, July 23, 2024 SAN FRANCISCO, Oct. 13, 2020 /PRNewswire/ — SkinCeuticals, the number one medical skin care brand, announces the launch of its biggest new product to date, P-TIOX, a new clinically-backed peptide serum designed to reduce the appearance of wrinkles and leave skin glowing like glass. This revolutionary serum delivers advanced wrinkle correction, improved skin smoothness and a radiant complexion.
Courtesy of SkinCeuticals
Inspired by the effects of neurotoxin injections and the emerging Microtox trend, P-TIOX features a patent-pending blend of advanced peptides amplified by synergistic active ingredients to reduce the appearance of nine types of shrinkage lines and reveal visibly smoother, more radiant skin on all skin types and tones.
P-TIOX is doctor-tested as a complement to neurotoxin injections and is effective on its own in achieving needle-free wrinkle correction without the aid of specialized injectables. Additionally, P-TIOX is formulated with a novel blend of advanced peptides amplified by powerful active ingredients.
This patent-pending combination of ingredients has demonstrated powerful synergistic effects compared to peptide-based formulations alone.1:
- Inspired by the effects of neurotoxin injections, this is an advanced peptide complex containing 2% Acetyl Hexapeptide-8 + 2% Dipeptide Diaminobutyroyl to reduce the appearance of contraction lines.
- 5% Polyhydroxy Glass Skin Complex Acid + 5% Niacinamide + 1% Laminaria The extracts maximize hydration while gently exfoliating to improve skin texture and radiance.
Results can be seen within one week. After 12 weeks, average results are:
- After 1 week: Skin will be visibly smoother, pores will be less visible and skin will have a glass-like glow.2
- In 12 weeks: 9 types of shrinkage lines that cannot be treated with neurotoxin injections are visibly reduced.2
“As pioneers in integrative skin care, our goal was to offer an innovation that pairs perfectly with our cutting-edge in-office treatment, neurotoxin injectables,” he said. Angela Hildebrand“Our physician partners are thrilled. It’s great for both patients who need injectables and those who are looking for similar anti-aging results but can’t yet afford injectable treatments,” said SkinCeuticals U.S. General Manager.
“As we age, dynamic facial expressions imprint contraction lines on the skin,” says Dr. , a partner physician at SkinCeuticals. Rosalyn George“P-TIOX has been clinically proven to reduce the appearance of nine types of contraction lines, even in areas of the face that traditionally could not be treated with neurotoxin injections. Additionally, after just one week of use, with or without neurotoxin injections, it improves skin texture and radiance, resulting in an overall smoother, glass-like complexion.”
To use, apply 4-6 drops of P-TIOX twice daily after your antioxidant serum. Apply moisturizer and sunscreen in the morning. SkinCeuticals P-TIOX: $148 Available to purchase at your local affiliated skin care professional nationwide (find them at skinCeuticals.com/locate) or at SkinCeuticals.com.
About SkinCeuticals
SkinCeuticals®is the number one medical skin care brand in the United States and a leader in antioxidant technology, founded in 2008. Dallas, Texas In 1997, we discovered, developed and delivered advanced, scientifically-backed cosmetic treatments.® SkinCeuticals products are proven to dramatically improve skin health by protecting against environmental damage, visibly improving skin clarity, tone and texture, and reducing the appearance of fine lines and wrinkles. SkinCeuticals is distributed in over 6,000 clinics nationwide, including over 100 dermatologists and plastic surgeons who sell SkinCeuticals exclusively through their flagship programs and the SkinCeuticals Skin Lab™. SkinCeuticals places a special emphasis on SkinCeuticals’ integrative skin care approach, combining clinical skin care with in-office treatments. For more information, visit the brand on Facebook, Twitter, Instagram or at www.SkinCeuticals.com.
contact
Laura Cummins SkinCeuticals: (212) 984-4907/ [email protected]
1Protocol: Human ex vivo skin tissue was used in this study. After culturing the skin tissue for 2 days, the skin tissue was UV irradiated (30J/cm2 UVA and 50mJ/cm2 UVB) for 4 consecutive days. After each irradiation, fresh culture medium was replaced and samples were applied to the skin surface. The positive control (VC+VE) group was administered under liquid, while the sample group was administered on the surface. After 4 consecutive days of irradiation, the ex vivo skin tissue was cultured for another 3 days, during which no irradiation was performed and only sample administration was performed. After the end of treatment, skin samples were taken and then biomarker analysis was performed. Immunofluorescence (IF) was used to detect the expression of collagen I, collagen III, collagen IV, and collagen XVII, immunohistochemistry (IC) was used to detect the expression of elastin, Ki67, Victoria blue staining was used to detect the expression of elastic fiber, Masson staining was used to detect the expression of collagen fiber, and ELISA was used to detect the expression of MMP-1.
2Protocol: A 12-week single-center clinical trial was conducted in 82 women with Fitzpatrick skin type I-VI (52% sensitive skin), age 34-65 years, and mild to moderate wrinkles, fine lines, visible pores, and dermatologist-assessed skin roughness. After cleansing, P-TIOX was applied twice daily in the morning and evening, followed by a standard moisturizer and sunscreen (AM). Subjects were instructed to avoid topical facial applications for at least 2 days prior to baseline. Efficacy assessments were conducted at baseline, weeks 1, 2, 4, 8, and 12.
SOURCE SkinCeuticals
